Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

The purpose of this study is to assess the safety and immunogenicity of GSK's combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae

  • 0 views
  • 16 Apr, 2021
  • 3 locations
Evaluation of Clinical Efficacy of Different Injection Therapies for Treating Humeral Epicondylopathy

everyday stretching and strengthening exercises. Evaluation of clinical effectiveness of the treatment will be based on objective measurements such as range of motion, limb girth, grip strength, X-ray and

  • 0 views
  • 19 Feb, 2021
  • 1 location
Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children

We can not predict which wheezing child younger than 3 years of age benefits from systemic glucocorticoid and which one does not. It is not known whether the differences in the efficacy are related to the differences in viral etiology, atopy, immunogical maturity or age of the patient. The study …

prednisolone
atopy
  • 0 views
  • 07 Nov, 2020
  • 1 location
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

recombinant vaccine, or the egg-based vaccine) over two influenza seasons (2018-2019, 2019-2020, 2020-2021).

vaccination
trivalent influenza vaccine
influenza vaccination
  • 321 views
  • 26 Jan, 2021
  • 10 locations
Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4

Subjects will be recruited and divided into 3 groups: Experimental Group (384 subjects): 1st dose : combined vaccination of COVIV+IIV4, 2nd dose: combined vaccination of COVIV+PPV23; Control Group A (384 subjects): 1st dose: COVIV only, 2nd dose: COVIV only; Control Group B (384 subjects): 1st dose: IIV4 only, 2nd dose: …

  • 0 views
  • 24 Mar, 2021
  • 3 locations
Randomized Embedded Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of …

  • 2104 views
  • 26 Jan, 2021
  • 108 locations
Safety Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

A randomized phase IV study of the liquid pentavalent combination vaccine to evaluate the safety, immunogenicity (short term and long term) and clinical consistency of three production lots of the vaccine.

hepatitis b
hepatitis b antigen
hepatitis b surface antigen
hepatitis
combination vaccines
  • 17 views
  • 07 Nov, 2020
  • 1 location
A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults

(i.e., COVID-19, influenza, and other known viral respiratory pathogens) morbidity and mortality in a high-risk cohort of adults with established atherosclerotic cardiovascular disease (ASCVD).

cold
coronavirus infection
SARS
influenza
myocardial infarction
  • 0 views
  • 26 Jan, 2021
  • 1 location
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults

intervention, potentially including COVID-19 episodes. The other will be declared secondary endpoint. Other secondary endpoints include: all SARS-CoV-2 infections (including asymptomatic infections), influenza

strain
influenza
pneumonia
antibiotics
respiratory tract infection
  • 32 views
  • 29 May, 2021
  • 20 locations
Cholecalciferol to Improve the Outcomes of COVID-19 Patients

The recent inception of the coronavirus SARS-CoV-2, responsible for the coronavirus disease (COVID-19), has caused thousands of deaths globally. The most frequently reported complications among COVID-19 patients are from respiratory involvement. Vitamin D has immunomodulatory effects that could protect against COVID-19 infection. Indeed, there is good evidence from randomized clinical …

coronavirus infection
SARS
COPD
mechanical ventilation
oximetry
  • 7 views
  • 11 Apr, 2021
  • 1 location